Biotech Acquisition Company (BIOT)
|Net Income (ttm)||n/a|
|Trading Day||April 19|
|Day's Range||9.75 - 9.82|
|52-Week Range||9.54 - 9.95|
Biotech Acquisition Company Announces Separate Trading of its Class A Ordinary Shares and Warrants Commencing March 1...
NEW YORK, March 15, 2021 /PRNewswire/ -- Biotech Acquisition Company (NASDAQ: BIOTU) (the "Company") announced that, commencing March 18, 2021, holders of the units sold in the Company's initial public ...
New York, NY, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Biotech Acquisition Company (the “Company”) announced today that it has closed its initial public offering of 23,000,000 units, including 3,000,000 units ...
New York, NY, Jan. 25, 2021 (GLOBE NEWSWIRE) -- Biotech Acquisition Company (the “Company”), a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acqui...
Biotech Acquisition Company, a blank check company formed by CRO and venture investor SPRIM targeting the biotech industry, filed on Thursday with the SEC for an initial public offering.
Biotech Acquisition Company has filed to go public with an IPO on the NASDAQ.
Biotech Acquisition is a recently organized blank check company incorporated as a Cayman Islands exempted company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one business. We intend to focus on industries that complement our sponsor and management team’s background as affiliates of SPRIM Global Investments, a leading life science investment firm in the healthcare industry. As such, our target sector is expected to be the healthcare... [Read more...]
Blank Checks / SPAC
|IPO Date |
Jan 26, 2021
|Stock Exchange |
|Ticker Symbol |